Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Beatriz Bellosillo Paricio"'
Autor:
Maria Milagro Montero, Max Hardy-Werbin, Soledad Gonzalez Gallardo, Erica Torres, Rebeca Rueda, Irene Hannet, James T Kirk, Thomas D Yager, Krupa Navalkar, Maria del Mar Arenas, Itziar Arietta-Aldea, Silvia Castañeda, Joan Gómez-Junyent, Silvia Gómez-Zorrilla, Roberto Guerri-Fernández, Francisca Sanchez-Martinez, Immaculada López-Montesinos, Ivan Pelegrín, Elena Sendra, Luisa Sorlí, Judith Villar-García, Beatriz Bellosillo Paricio, Juan Pablo Horcajada
Rationale: Tools for the evaluation of COVID-19 severity would help clinicians with triage decisions, especially the decision whether to admit to ICU. Objective: Evaluation of SeptiCyte RAPID, a host immune response assay (Immunexpress, Seattle USA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b79c6ac89e6adc1839ec7f8eff9b7157
https://doi.org/10.21203/rs.3.rs-1942658/v1
https://doi.org/10.21203/rs.3.rs-1942658/v1
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Autor:
Rodrigo Almeida Toledo, Javier Hernandez Losa, Noelia Tarazona, Marta Dueñas Porto, Karmele Valencia Leoz, Marta Rodríguez, Beatriz Bellosillo Paricio, Sara Lopez-Tarruella, Laura Muinelo Romay, María Eugenia Sarasquete, Silvia Calabuig-Fariñas, Julie Earl
Publikováno v:
Journal of Visualized Experiments.
The term liquid biopsy (LB) refers to molecules such as proteins, DNA, RNA, cells, or extracellular vesicles in blood and other bodily fluids that originate from the primary and/or metastatic tumor. LB has emerged as a mainstay in translational resea
Autor:
Antonio Llombart-Cussac, Andrea Malfettone, Joan Albanell, Lourdes Calvo, Beatriz Bellosillo Paricio, Vanesa Quiroga, Miguel Gil, Juan de la Haba, Jose Perez-Garcia, Miguel Sampayo, Begoña Bermejo, Enrique Espinosa, Meritxell Bellet, Laura Comerma Blesa, Giuseppe Curigliano, Ana Santaballa, Javier Cortes, Alessandro Marco Minisini, Manuel Ruiz Borrego, Federico Rojo Todo
Publikováno v:
Cancer Research. 81:PS10-27
Background: The addition of a cyclin-dependent kinase 4-6 inhibitor (CDK4/6i) to letrozole or fulvestrant significantly improves progression-free survival (PFS) and overall survival (OS) in HR[+]/HER2[-] MBC pts. At present, the optimal endocrine tre
Autor:
Margarita Alberola-Ferranti, Santiago Ramón y Cajal, Montserrat Munill-Ferrer, Coro Bescós-Atín, Javier Hernández-Losa, Rosa Somoza Lopez de Haro, Adaia Valls-Ontañón, Beatriz Bellosillo-Paricio
Publikováno v:
Medicina Clínica (English Edition). 152:174-180
Background and objectives Although there is scientific evidence demonstrating causation of human papilloma virus (HPV) on squamous cell carcinoma of head and neck, its percentage of causality on the anatomic region remains in dispute. This study was
Autor:
Rosa Somoza Lopez de Haro, Javier Hernández-Losa, Coro Bescós-Atín, Beatriz Bellosillo-Paricio, Santiago Ramón y Cajal, Margarita Alberola-Ferranti, Adaia Valls-Ontañón, Montserrat Munill-Ferrer
Publikováno v:
Medicina Clínica. 152:174-180
Resumen Antecedentes y objetivos Aunque existe evidencia cientifica que demuestra la relacion de causalidad del virus papiloma humano (VPH) sobre el carcinoma escamoso de cabeza y cuello, su porcentaje de causalidad en las distintas regiones anatomic
Autor:
Deepti Radia, Anju Kanda, Yvonne Francis, Claire N. Harrison, Shahram Kordasti, Ken I. Mills, Paul Lavender, Richard Dillon, Alexander C. Smith, Sophie Ord, Ghulam J. Mufti, William Villiers, Manohursingh Runglall, James Kaufman-Cook, Donal P. McLornan, Samah Alimam, Michael A. Simpson, Prodromos Chatzikyriakou, Claire Woodley, Beatriz Bellosillo Paricio
Publikováno v:
Alimam, S, Villiers, W, Dillon, R, Simpson, M, Runglall, M, Smith, A, Chatzikyriakou, P, Lavender, P, Kanda, A, Mills, K, Bellosillo Paricio, B, Kaufman-Cook, J, Ord, S, Kordasti, S, Radia, D, Woodley, C, Francis, Y, Mufti, G, McLornan, D P & Harrison, C N 2021, ' Patients with triple-negative, JAK2V617F-and CALR-mutated essential thrombocythemia share a unique gene expression signature ', Blood Advances, vol. 5, no. 4, pp. 1059-1068 . https://doi.org/10.1182/bloodadvances.2020003172
Blood Adv
Blood Adv
Approximately 10% to 15% of patients with essential thrombocythemia (ET) lack the common driver mutations, so-called “triple-negative” (TN) disease. We undertook a systematic approach to investigate for somatic mutations and delineate gene expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee9a5e0b7b300258cf1fa54f1ebfdab
https://pure.qub.ac.uk/en/publications/patients-with-triplenegative-jak2v617f-and-calrmutated-essential-thrombocythemia-share-a-unique-gene-expression-signature(92765c90-b4d8-4543-abaf-cf4d2f5fcfeb).html
https://pure.qub.ac.uk/en/publications/patients-with-triplenegative-jak2v617f-and-calrmutated-essential-thrombocythemia-share-a-unique-gene-expression-signature(92765c90-b4d8-4543-abaf-cf4d2f5fcfeb).html
Autor:
Beatriz Bellosillo Paricio, Alberto Álvarez Larrán, Szukalski Łukasz, Marcio Andrade-Campos, Maria Laura Fox, Aitor Abuin Blanco, Celsa Quinteiro García, Jesús María González Martín, Alejandro Martín Martín, Anna Czyż, Manuel Mateo Pérez Encinas, K Lewandowki, Elena Magro Mazo, Juan Carlos Hernandez Boluda, Aleksandra Gołos, Mercedes Gasior Kabat, María Soledad Noya Pereira, Ruth Stuckey, María Teresa Gómez-Casares, Francisca Ferrer-Marín, José María Raya, Marta Sobas
Publikováno v:
EUROPEAN JOURNAL OF HAEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
OBJECTIVES: In patients with essential thrombocythemia (ET), after the JAK2V617F driver mutation, mutations in CALR are common (classified as type-1, 52-bp deletion, or type-2, 5-bp insertion). CALR mutations have generally been associated with a low
Autor:
Albert Font, Raquel Albero Gonzalez, Beatriz Bellosillo Paricio, Lara Pijuan Andujar, Clara Martin Ontiyuelo, Raquel Longaron Rozalen, Victor Curull Serrano, Alba Dalmases Massegú, Roberto Chalela Rengifo
Publikováno v:
Lung Cancer.
Autor:
Mary Frances McMullin, Melanie J. Percy, Sylvie Hermouet, Jiří Schwarz, Naomi Porret, Kais Hussein, Susanne Schnittger, Radek C. Skoda, Luz Maria Martinez-Aviles, Eric Lippert, Beatriz Bellosillo Paricio, Stéphane Giraudier, Holger Cario
1.2 OMIM# of the disease 187950 (Thrombocythemia 1/THCYT1, autosomal dominant); 601977 (thrombocythemia 2/THCYT2, autosomal dominant and autosomal recessive); 614521 (thrombocythemia 3/THCYT3, autosomal dominant with incomplete penetrance); 300331 (t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a977a1e6eb1ce8ed6409827da35c8be
https://europepmc.org/articles/PMC3895637/
https://europepmc.org/articles/PMC3895637/
Autor:
Sylvie Hermouet, François Girodon, Lukáš Plank, Serge Carillo, Melanie J. Percy, Eric Lippert, Beatriz Bellosillo Paricio, Lars Palmqvist, Mary Frances McMullin, Jiri Schwarz, Heike L. Pahl, Alessandro M. Vannucchi, Susanne Schnittger, Niels Pallisgaard, Stéphane Giraudier, Celeste Bento, Radek C. Skoda
Publikováno v:
Blood. 118:2809-2809
Abstract 2809 Background: The MPN&MPNr-EuroNet network, created in November 2009, is supported by the European program COST (CoOperation in Science and Technology). It is open to all colleagues active in the fields of myeloprolifeative neoplasms (MPN